% alzhub.org library filter
% Source: https://alzhub.org/research?q=lecanemab&score_min=67
% 37 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{perry2026-41689888,
  author  = {Perry, Richard and Kipps, Christopher and Martín, Maria Eugenia Soto and Bozzali, Marco and Logroscino, Giancarlo and Trafford, Sarah and Dhadda, Shobha and Kanekiyo, Michio and others},
  title   = {{Lecanemab for treatment of individuals with early Alzheimer's Disease (AD) who are apolipoprotein E ε4 (ApoE ε4) non-carriers or heterozygotes}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2026},
  doi     = {10.1016/j.tjpad.2026.100507},
  pmid    = {41689888},
  url     = {https://doi.org/10.1016/j.tjpad.2026.100507}
}

@article{terao2024-38253184,
  author  = {Terao, Itsuki and Kodama, Wakako},
  title   = {{Comparative efficacy, tolerability and acceptability of donanemab, lecanemab, aducanumab and lithium on cognitive function in mild cognitive impairment and Alzheimer's disease: A systematic review and network meta-analysis}},
  journal = {Ageing research reviews},
  year    = {2024},
  doi     = {10.1016/j.arr.2024.102203},
  pmid    = {38253184},
  url     = {https://doi.org/10.1016/j.arr.2024.102203}
}

@article{terao2025-40386876,
  author  = {Terao, Itsuki and Kodama, Wakako},
  title   = {{Comparative efficacy, tolerability, and acceptability of aducanumab, lecanemab, and donanemab with repetitive transcranial magnetic stimulation on cognitive function in mild cognitive impairment and Alzheimer's disease: A systematic review and network meta-analysis}},
  journal = {Journal of psychopharmacology (Oxford, England)},
  year    = {2025},
  doi     = {10.1177/02698811251340901},
  pmid    = {40386876},
  url     = {https://doi.org/10.1177/02698811251340901}
}

@article{swanson2021-33865446,
  author  = {Swanson, C. J. and Zhang, Y. and Dhadda, S. and Wang, J. and Kaplow, J. and Lai, R. Y. K. and Lannfelt, L. and Bradley, H. and others},
  title   = {{A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody}},
  journal = {Alzheimer's research \& therapy},
  year    = {2021},
  doi     = {10.1186/s13195-021-00813-8},
  pmid    = {33865446},
  url     = {https://doi.org/10.1186/s13195-021-00813-8}
}

@article{mcdade2022-36544184,
  author  = {McDade, E. and Cummings, J. L. and Dhadda, S. and Swanson, C. J. and Reyderman, L. and Kanekiyo, M. and Koyama, A. and Irizarry, M. and others},
  title   = {{Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study}},
  journal = {Alzheimer's research \& therapy},
  year    = {2022},
  doi     = {10.1186/s13195-022-01124-2},
  pmid    = {36544184},
  url     = {https://doi.org/10.1186/s13195-022-01124-2}
}

@article{vandyck2023-36449413,
  author  = {van Dyck, C. H. and Swanson, C. J. and Aisen, P. and Bateman, R. J. and Chen, C. and Gee, M. and Kanekiyo, M. and Li, D. and others},
  title   = {{Lecanemab in Early Alzheimer's Disease}},
  journal = {The New England journal of medicine},
  year    = {2023},
  doi     = {10.1056/nejmoa2212948},
  pmid    = {36449413},
  url     = {https://doi.org/10.1056/nejmoa2212948}
}

@article{chowdhury2023-37902139,
  author  = {Chowdhury, Selia and Chowdhury, Nurjahan Shipa},
  title   = {{Novel anti-amyloid-beta (Aβ) monoclonal antibody lecanemab for Alzheimer's disease: A systematic review}},
  journal = {International journal of immunopathology and pharmacology},
  year    = {2023},
  doi     = {10.1177/03946320231209839},
  pmid    = {37902139},
  url     = {https://doi.org/10.1177/03946320231209839}
}

@article{solopova2023-38086820,
  author  = {Solopova, E. and Romero-Fernandez, W. and Harmsen, H. and Ventura-Antunes, L. and Wang, E. and Shostak, A. and Maldonado, J. and Donahue, M. J. and others},
  title   = {{Fatal iatrogenic cerebral β-amyloid-related arteritis in a woman treated with lecanemab for Alzheimer's disease}},
  journal = {Nature communications},
  year    = {2023},
  doi     = {10.1038/s41467-023-43933-5},
  pmid    = {38086820},
  url     = {https://doi.org/10.1038/s41467-023-43933-5}
}

@article{honig2024-38730496,
  author  = {Honig, L. S. and Sabbagh, M. N. and van Dyck, C. H. and Sperling, R. A. and Hersch, S. and Matta, A. and Giorgi, L. and Gee, M. and others},
  title   = {{Updated safety results from phase 3 lecanemab study in early Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2024},
  doi     = {10.1186/s13195-024-01441-8},
  pmid    = {38730496},
  url     = {https://doi.org/10.1186/s13195-024-01441-8}
}

@article{qiao2023-37213538,
  author  = {Qiao, Y. and Chi, Y. and Zhang, Q. and Ma, Y.},
  title   = {{Safety and efficacy of lecanemab for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials}},
  journal = {Frontiers in aging neuroscience},
  year    = {2023},
  doi     = {10.3389/fnagi.2023.1169499},
  pmid    = {37213538},
  url     = {https://doi.org/10.3389/fnagi.2023.1169499}
}

@article{hossain2024-38867460,
  author  = {Hossain, M. F. and Husna, A. U. and Kharel, M.},
  title   = {{Use of lecanemab for the treatment of Alzheimer's disease: A systematic review}},
  journal = {Brain and behavior},
  year    = {2024},
  doi     = {10.1002/brb3.3592},
  pmid    = {38867460},
  url     = {https://doi.org/10.1002/brb3.3592}
}

@article{cohen2023-37874099,
  author  = {Cohen, S and van Dyck, C H and Gee, M and Doherty, T and Kanekiyo, M and Dhadda, S and Li, D and Hersch, S and others},
  title   = {{Lecanemab Clarity AD: Quality-of-Life Results from a Randomized, Double-Blind Phase 3 Trial in Early Alzheimer's Disease}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2023},
  doi     = {10.14283/jpad.2023.123},
  pmid    = {37874099},
  url     = {https://doi.org/10.14283/jpad.2023.123}
}

@article{vandyck2023-22dd8fce,
  author  = {van Dyck, C. H. and Swanson, C. J. and Aisen, P. and Bateman, R. J. and Chen, C. and Gee, M. and Kanekiyo, M. and Li, D. and Reyderman, L. and Cohen, S. and Froelich, L. and Katayama, S. and Sabbagh, M. and Vellas, B. and Watson, D. and Dhadda, S. and Irizarry, M. and Kramer, L. D. and Iwatsubo, T.},
  title   = {{Lecanemab in Early Alzheimer's Disease}},
  journal = {New England Journal of Medicine},
  year    = {2023},
  pmid    = {36449413}
}

@article{chen2025-41070709,
  author  = {Chen, S. and Ou, R. and Wei, Q. and Li, C. and Song, W. and Zhao, B. and Yang, J. and Fu, J. and others},
  title   = {{Lecanemab treatment for Alzheimer's Disease of varying severities and associated plasma biomarkers monitoring: A multi-center real-world study in China}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2025},
  doi     = {10.1002/alz.70750},
  pmid    = {41070709},
  url     = {https://doi.org/10.1002/alz.70750}
}

@article{kang2026-42535277,
  author  = {Kang, Sung Hoon and Park, Yu Jeong and Lee, Seungyun and Kang, Jimin and Lee, Seongin and Lee, Eun Seong and Jung, Hye Na and Ryoo, Inseon and others},
  title   = {{Heterogeneity in plasma p-tau217 response and its association with cognitive trajectories under lecanemab treatment}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2026},
  doi     = {10.1002/alz.71705},
  pmid    = {42535277},
  url     = {https://doi.org/10.1002/alz.71705}
}

@article{wang2025-40308765,
  author  = {Wang, H. and Pan, J. and Zhang, M. and Tan, Z.},
  title   = {{Re-evaluation of the efficacy and safety of anti-Aβ monoclonal antibodies (lecanemab/donanemab) in the treatment of early Alzheimer's disease}},
  journal = {Frontiers in pharmacology},
  year    = {2025},
  doi     = {10.3389/fphar.2025.1599048},
  pmid    = {40308765},
  url     = {https://doi.org/10.3389/fphar.2025.1599048}
}

@article{abdelazim2024-38565747,
  author  = {Abdelazim, K. and Allam, A. A. and Afifi, B. and Abdulazeem, H. and Elbehiry, A. I.},
  title   = {{The efficacy and safety of lecanemab 10 mg/kg biweekly compared to a placebo in patients with Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials}},
  journal = {Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology},
  year    = {2024},
  doi     = {10.1007/s10072-024-07477-w},
  pmid    = {38565747},
  url     = {https://doi.org/10.1007/s10072-024-07477-w}
}

@article{noguchishinohara2025-41276859,
  author  = {Noguchi-Shinohara, M. and Yoshinobu, T. and Ozaki, T. and Muramatsu, D. and Shima, A. and Sakashita, Y. and Tada, Y. and Yamaguchi, H. and others},
  title   = {{Higher phosphorylated tau levels predict cognitive decline and amyloid-related imaging abnormalities during lecanemab treatment: clinical practice data}},
  journal = {Alzheimer's research \& therapy},
  year    = {2025},
  doi     = {10.1186/s13195-025-01912-6},
  pmid    = {41276859},
  url     = {https://doi.org/10.1186/s13195-025-01912-6}
}

@article{paczynski2025-40354064,
  author  = {Paczynski, M. and Hofmann, A. and Posey, Z. and Gregersen, M. and Rudman, M. and Ellington, D. and Aldinger, M. and Musiek, E. S. and Holtzman, D. M. and Bateman, R. J. and others},
  title   = {{Lecanemab Treatment in a Specialty Memory Clinic}},
  journal = {JAMA Neurology},
  year    = {2025},
  doi     = {10.1001/jamaneurol.2025.1232},
  pmid    = {40354064},
  url     = {https://doi.org/10.1001/jamaneurol.2025.1232}
}

@article{knopman2023-37295957,
  author  = {Knopman, D. S. and Hershey, L.},
  title   = {{Implications of the Approval of Lecanemab for Alzheimer Disease Patient Care: Incremental Step or Paradigm Shift?}},
  journal = {Neurology},
  year    = {2023},
  doi     = {10.1212/wnl.0000000000207438},
  pmid    = {37295957},
  url     = {https://doi.org/10.1212/wnl.0000000000207438}
}

@article{bregman2025-40437535,
  author  = {Bregman, N. and Nathan, T. and Shir, D. and Omer, N. and Levy, M. H. and David, A. B. and Aizenstien, O. and Lotan, E. and others},
  title   = {{Lecanemab in clinical practice: real-world outcomes in early Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2025},
  doi     = {10.1186/s13195-025-01763-1},
  pmid    = {40437535},
  url     = {https://doi.org/10.1186/s13195-025-01763-1}
}

@article{shang2025-41250246,
  author  = {Shang, Jia and Zhong, Siyan and Shang, Li and Zeng, Qingze and Zhao, Shuai and Luo, Xiao and Li, Kaicheng and Zhang, Xinyi and others},
  title   = {{Real-world application of lecanemab in early-stage alzheimer's disease: a single-center prospective cohort analysis}},
  journal = {Alzheimer's research \& therapy},
  year    = {2025},
  doi     = {10.1186/s13195-025-01886-5},
  pmid    = {41250246},
  url     = {https://doi.org/10.1186/s13195-025-01886-5}
}

@article{shimasaki2026-41936348,
  author  = {Shimasaki, Ryosuke and Kurihara, Masanori and Bannai, Taro and Hatano, Keiko and Suzuki, Fumio and Tokumaru, Aya Midori and Ishii, Kenji and Ihara, Ryoko and others},
  title   = {{Amyloid-related imaging abnormalities in Japanese patients with Alzheimer's disease treated with Lecanemab: A real-world study}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2026},
  doi     = {10.1016/j.tjpad.2026.100562},
  pmid    = {41936348},
  url     = {https://doi.org/10.1016/j.tjpad.2026.100562}
}

@article{arroyopacheco2025-39638097,
  author  = {Arroyo-Pacheco, N. and Sarmiento-Blanco, S. and Vergara-Cadavid, G. and Castro-Leones, M. and Contreras-Puentes, N.},
  title   = {{Monoclonal therapy with lecanemab in the treatment of mild Alzheimer's disease: A systematic review and meta-analysis}},
  journal = {Ageing research reviews},
  year    = {2025},
  doi     = {10.1016/j.arr.2024.102620},
  pmid    = {39638097},
  url     = {https://doi.org/10.1016/j.arr.2024.102620}
}

@article{berry2023-37040116,
  author  = {Berry, D. A. and Dhadda, S. and Kanekiyo, M. and Li, D. and Swanson, C. J. and Irizarry, M. and Kramer, L. D. and Berry, S. M.},
  title   = {{Lecanemab for Patients With Early Alzheimer Disease: Bayesian Analysis of a Phase 2b Dose-Finding Randomized Clinical Trial}},
  journal = {JAMA network open},
  year    = {2023},
  doi     = {10.1001/jamanetworkopen.2023.7230},
  pmid    = {37040116},
  url     = {https://doi.org/10.1001/jamanetworkopen.2023.7230}
}

@article{qiao2024-38429615,
  author  = {Qiao, Y. and Gu, J. and Yu, M. and Chi, Y. and Ma, Y.},
  title   = {{Comparative Efficacy and Safety of Monoclonal Antibodies for Cognitive Decline in Patients with Alzheimer's Disease: A Systematic Review and Network Meta-Analysis}},
  journal = {CNS drugs},
  year    = {2024},
  doi     = {10.1007/s40263-024-01067-2},
  pmid    = {38429615},
  url     = {https://doi.org/10.1007/s40263-024-01067-2}
}

@article{hsu2025-40316479,
  author  = {Hsu, C. W. and Hsu, T. W. and Kao, Y. C. and Lin, Y. H. and Thompson, T. and Carvalho, A. F. and Stubbs, B. and Tseng, P. T. and others},
  title   = {{The efficacy and safety of anti-amyloid monoclonal antibody versus acetylcholinesterase inhibitor with an in-depth analysis across genotypes and disease stages: a systematic review and meta-analysis}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2025},
  doi     = {10.1016/j.tjpad.2025.100195},
  pmid    = {40316479},
  url     = {https://doi.org/10.1016/j.tjpad.2025.100195}
}

@article{wu2023-38017568,
  author  = {Wu, W. and Ji, Y. and Wang, Z. and Wu, X. and Li, J. and Gu, F. and Chen, Z.},
  title   = {{The FDA-approved anti-amyloid-β monoclonal antibodies for the treatment of Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials}},
  journal = {European journal of medical research},
  year    = {2023},
  doi     = {10.1186/s40001-023-01512-w},
  pmid    = {38017568},
  url     = {https://doi.org/10.1186/s40001-023-01512-w}
}

@article{shim2026-41352683,
  author  = {Shim, G. H. and Lau, E. C. Y. and Huynh, A. L. H. and Lu, C. Y. and Tan, E. C. K.},
  title   = {{Influence of patient characteristics on efficacy and safety of anti-amyloid monoclonal antibodies in Alzheimer's disease: A systematic review and meta-analysis}},
  journal = {Ageing research reviews},
  year    = {2026},
  doi     = {10.1016/j.arr.2025.102981},
  pmid    = {41352683},
  url     = {https://doi.org/10.1016/j.arr.2025.102981}
}

@article{jeremic2023-37423541,
  author  = {Jeremic, D. and Navarro-López, J. D. and Jiménez-Díaz, L.},
  title   = {{Efficacy and safety of anti-amyloid-β monoclonal antibodies in current Alzheimer's disease phase III clinical trials: A systematic review and interactive web app-based meta-analysis}},
  journal = {Ageing research reviews},
  year    = {2023},
  doi     = {10.1016/j.arr.2023.102012},
  pmid    = {37423541},
  url     = {https://doi.org/10.1016/j.arr.2023.102012}
}

@article{ebell2024-38253509,
  author  = {Ebell, M. H. and Barry, H. C. and Baduni, K. and Grasso, G.},
  title   = {{Clinically Important Benefits and Harms of Monoclonal Antibodies Targeting Amyloid for the Treatment of Alzheimer Disease: A Systematic Review and Meta-Analysis}},
  journal = {Annals of Family Medicine},
  year    = {2024},
  doi     = {10.1370/afm.3050},
  pmid    = {38253509},
  url     = {https://doi.org/10.1370/afm.3050}
}

@article{avgerinos2024-39468148,
  author  = {Avgerinos, K. I. and Manolopoulos, A. and Ferrucci, L. and Kapogiannis, D.},
  title   = {{Critical assessment of anti-amyloid-β monoclonal antibodies effects in Alzheimer's disease: a systematic review and meta-analysis highlighting target engagement and clinical meaningfulness}},
  journal = {Scientific reports},
  year    = {2024},
  doi     = {10.1038/s41598-024-75204-8},
  pmid    = {39468148},
  url     = {https://doi.org/10.1038/s41598-024-75204-8}
}

@article{chundu2025-40621323,
  author  = {Chundu, U. C. and Thiriveedhi, SR. and Bhatti, C. and Mupparaju, J. S. and Otinashvili, N. and Gelishvili, E.},
  title   = {{A Systematic Review of the Efficacy and Safety of Anti-amyloid Monoclonal Antibodies in Alzheimer's Disease}},
  journal = {Cureus},
  year    = {2025},
  doi     = {10.7759/cureus.85377},
  pmid    = {40621323},
  url     = {https://doi.org/10.7759/cureus.85377}
}

@article{chhabra2024-39432414,
  author  = {Chhabra, Akanksha and Solanki, Siddhant and Saravanabawan, Prithvi and Venkiteswaran, Arun and Nimmathota, NagaTarang and Modi, Nishi Manojkumar},
  title   = {{A systematic review of the efficacy and safety of anti-amyloid beta monoclonal antibodies in treatment of Alzheimer's disease}},
  journal = {Expert opinion on biological therapy},
  year    = {2024},
  doi     = {10.1080/14712598.2024.2416947},
  pmid    = {39432414},
  url     = {https://doi.org/10.1080/14712598.2024.2416947}
}

@article{su2025-40473116,
  author  = {Su, Ching-Hui and Chang, Ying-Tzu and Tseng, Huan-Shu and Kuo, Chan-Yen and Chen, Jin-Hua and Chien, Po-Yu and Chang, Yao-Jen and Hung, Chin-Chuan},
  title   = {{Comparisons of efficacy and safety of immunotherapies for Alzheimer's disease treatment: A network meta-analysis of randomised controlled trials}},
  journal = {Clinical medicine (London, England)},
  year    = {2025},
  doi     = {10.1016/j.clinme.2025.100336},
  pmid    = {40473116},
  url     = {https://doi.org/10.1016/j.clinme.2025.100336}
}

@article{vanetten2026-912127c4,
  author  = {van Etten, E. S. and others},
  title   = {{Amyloid-Related Imaging Abnormalities (ARIA) in Anti-Amyloid Therapies for Alzheimer's Disease: An Update from the Alzheimer's Association ARIA Workgroup}},
  journal = {Alzheimer's \& Dementia},
  year    = {2026}
}

@article{wang2022-35320578,
  author  = {Wang, D. and Kowalewski, E. K. and Koch, G.},
  title   = {{Application of Meta-analysis to Evaluate Relationships Among ARIA-E Rate, Amyloid Reduction Rate, and Clinical Cognitive Response in Amyloid Therapeutic Clinical Trials for Early Alzheimer's Disease}},
  journal = {Therapeutic innovation \& regulatory science},
  year    = {2022},
  doi     = {10.1007/s43441-022-00390-4},
  pmid    = {35320578},
  url     = {https://doi.org/10.1007/s43441-022-00390-4}
}